Overall
- Language
- English
- Conflict of Interest
- In relation to this article, we declare that there is no conflict of interest.
- Publication history
-
Received April 10, 2025
Revised September 4, 2025
Accepted September 23, 2025
Available online January 26, 2026
-
This is an Open-Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/bync/3.0) which permits
unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
Most Cited
Novel Hexagonal Ag0( NP) Decorated TiO2 Supported with Graphene Oxide Nano‑thin Films in the Efficient Degradation of Pharmaceuticals Under Visible Light
https://doi.org/10.1007/s11814-025-00569-z
Abstract
This study aims to synthesize hexagonal Ag0
nanoparticles (NPs) decorated with TiO2-
modified graphene oxide in a greener
template method to obtain a novel Ag0/
TiO2/GO heterojunction nanocomposite thin film photocatalyst. The synthesized
nanocomposites were characterized with SEM/TEM, DRS, AFM, BET, Raman, and XPS analytical tools. The material was
further utilized for the effective treatment of Ibuprofen (IBP) and Tetracycline (TC) under visible light illumination. The
synergistic effect between graphene oxide and metallic silver nanoparticles in the composite demonstrates a higher removal
efficiency of IBP and TC under visible light illumination by reducing the electron (e⁻) and hole (
h+) pairs recombination and
electron capture. The real applicability of the materials was further explored in the elimination of IBP/TC under the influence
of solution pH, initial pharmaceutical concentration, and various co-existing cations/anions. The degradation of IBP
is favorable at pH 4, while maximum TC removal is observed at pH 10. The hydroxyl radicals (·OH) and holes (
h+) are the
major active radicals involved in the degradation pathway. The reusability test involving simple washing showed the stability
of the nanocomposite thin film for prolonged treatment, which further reduces the overall treatment cost. A comparable
elimination efficiency of IBP and TC with distilled water and river water further demonstrated the photocatalyst’s potential
application for treating pharmaceutical-polluted wastewater on a large scale.

